D-1433-2020 Class II Terminated
FDA drug recall D-1433-2020 was initiated by MasterPharm LLC on Jul 2, 2020 and is designated Class II. Reason for recall: Lack of Processing Controls (lack of assurance of conformity to specifications). The recall status is terminated (terminated Feb 23, 2024). Affected quantity: 600 capsules.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 5, 2020
- Initiation Date
- Jul 2, 2020
- Termination Date
- Feb 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 600 capsules
Product Description
Progesterone Modified Release 100 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Reason for Recall
Lack of Processing Controls (lack of assurance of conformity to specifications).
Distribution Pattern
Nationwide in the U.S.
Code Information
02-12-2020:13@5, BUD 8/10/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1433-2020
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026